H
Horizon Therapeutics
Biotech & Life Sciences · Dublin, Ireland · Founded 2005 · IPO 2011 Decacorn
Global footprint
Where Horizon Therapeutics has talent and traffic
team presence
across markets
Patent intelligence
$100M patent portfolio · 70 active families
Where Horizon Therapeutics concentrates vs peers
Each axis is a top-10 topic across Horizon Therapeutics and its closest peers. #1 = 100, #10 = 10, absent = 0.
Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.
Capital deployed
Horizon Therapeutics's 8 investments and acquisitions.
Every disclosed deal where Horizon Therapeutics appeared as a backer or acquirer, 2010–2021. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
8 deals across Horizon Therapeutics's capital deployment.
Where the deals concentrate by sector, stage, and decade.
02 · Portfolio market map
Horizon Therapeutics's portfolio, mapped.
Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.
Market sentiment
What the market is saying about Horizon Therapeutics
An AI-synthesized read of the highest-engagement posts about Horizon Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Horizon Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.